Sanofi swoops on Ablynx as M&A spree up
French pharmaceutical company Sanofi has announced its second multi-billion euro takeover this month, offering to buy Belgian biotech company Ablynx for €3.9bn in cash.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: